Impetigo
https://en.wikipedia.org/wiki/Impetigo
☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine. relevance score : -100.0%
References
Impetigo: Diagnosis and Treatment 25250996Impetigo is the most common bacterial skin infection in children two to five years of age. There are two principal types: nonbullous (70% of cases) and bullous (30% of cases). Nonbullous impetigo, or impetigo contagiosa, is caused by Staphylococcus aureus or Streptococcus pyogenes, and is characterized by honey-colored crusts on the face and extremities. Impetigo primarily affects the skin or secondarily infects insect bites, eczema, or herpetic lesions. Bullous impetigo, which is caused exclusively by S. aureus, results in large, flaccid bullae and is more likely to affect intertriginous areas. Both types usually resolve within two to three weeks without scarring, and complications are rare, with the most serious being poststreptococcal glomerulonephritis. Treatment includes topical antibiotics such as mupirocin, retapamulin, and fusidic acid. Oral antibiotic therapy can be used for impetigo with large bullae or when topical therapy is impractical. Amoxicillin/clavulanate, dicloxacillin, cephalexin, clindamycin, doxycycline, minocycline, trimethoprim/sulfamethoxazole, and macrolides are options, but penicillin is not. Topical disinfectants are inferior to antibiotics and should not be used. Empiric treatment considerations have changed with the increasing prevalence of antibiotic-resistant bacteria, with methicillin-resistant S. aureus, macrolide-resistant streptococcus, and mupirocin-resistant streptococcus all documented. Fusidic acid, mupirocin, and retapamulin cover methicillin-susceptible S. aureus and streptococcal infections. Clindamycin proves helpful in suspected methicillin-resistant S. aureus infections. Trimethoprim/sulfamethoxazole covers methicillin-resistant S. aureus infection, but is inadequate for streptococcal infection.
Impetigo 28613693 NIH
Impetigo ke ts'oaetso e tloaelehileng ea letlalo e bakoang ke libaktheria tse itseng, e hasana habonolo ka ho kopana. Hangata e hlaha e le maqeba a mafubelu a koahetsoeng ka lekhapetla le mosehla 'me e ka baka ho hlohlona kapa bohloko. Tšoaetso ena e atile haholo ho bana ba lulang libakeng tse futhumetseng, tse mongobo. E ka hlaha e le machache kapa ntle le 'ona. Le hoja hangata e ama sefahleho, e ka etsahala kae kapa kae moo ho nang le lekhalo letlalong. Tlhahlobo haholo-holo e itšetlehile ka matšoao le hore na e shebahala joang. Kalafo hangata e kenyelletsa lithibela-mafu, ka bobeli le ka molomo, hammoho le taolo ea matšoao.
Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria. It most commonly presents as erythematous plaques with a yellow crust and may be itchy or painful. The lesions are highly contagious and spread easily. Impetigo is a disease of children who reside in hot humid climates. The infection may be bullous or nonbullous. The infection typically affects the face but can also occur in any other part of the body that has an abrasion, laceration, insect bite or other trauma. Diagnosis is typically based on the symptoms and clinical manifestations alone. Treatment involves topical and oral antibiotics and symptomatic care.
Impetigo hangata e bakoa ke Staphylococcus aureus kapa Streptococcus pyogenes. Ka ho kopana e ka hasana hohle kapa pakeng tsa batho. Tabeng ea bana, e tšoaetsanoa ho banab’abo bona.
Kalafo hangata e sebelisoa ka litlolo tsa lithibela-mafu tse kang mupirocin kapa fusidic acid. Lithibela-mafu ka molomo, tse kang cefalexin, li ka sebelisoa haeba libaka tse kholo li ameha.
Impetigo e amme batho ba ka bang dimilione tse 140 (2% ya baahi ba lefatshe) ka 2010. E ka etsahala dilemong dife kapa dife, empa e atile haholo baneng ba banyenyane. Mathata a ka kenyelletsa cellulitis kapa poststreptococcal glomerulonephritis.
○ Kalafo - Lithethefatsi tsa OTC
* Kaha impetigo ke lefu le tšoaetsanoang, litlolo tsa steroid ha lia lokela ho sebelisoa. Haeba u na le bothata ba ho khetholla liso tsa impetigo ho eczema, ka kopo nka li-antihistamine tsa OTC ntle le ho sebelisa litlolo tsa steroid.
#OTC antihistamine
* Ka kopo, tlotsa setlolo sa lithibela-mafu sa OTC sebakeng seo.
#Bacitracin
#Polysporin